Eli Lilly and Company v. Sun Pharmaceutical Industries
Petition for certiorari denied on May 16, 2011
Issue: Whether the Federal Circuit erred in holding that when a chemical composition has been patented, a second patent may not be issued for any use of the composition that was disclosed in the text of the composition patent.
SCOTUSblog Coverage
- Petition of the day (Kiran Bhat, March 18, 2011)
Briefs and Documents
Certiorari-stage documents
- Opinion below (Fed. Cir.)
- Petition for certiorari
- Brief in opposition
- Amicus brief of the Biotechnology Industry Organization
- Amicus brief of Patent Docs
- Amicus brief of the Pharmaceutical Research and Manufacturers of America
- Amicus brief of the Washington Legal Foundation
- Petitioner's reply
[##CERT-STAGE##]